Anne Borgman
Chief Tech/Sci/R&D Officer bij SUTRO BIOPHARMA, INC.
Vermogen: 137 713 $ op 31-03-2024
Actieve functies van Anne Borgman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NEXTCURE, INC. | Director/Board Member | 01-10-2021 | - |
| Independent Dir/Board Member | 01-10-2021 | - | |
| CURIS, INC. | Director/Board Member | 01-10-2022 | - |
| Independent Dir/Board Member | 01-10-2022 | - | |
| SUTRO BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 28-02-2023 | - |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Director/Board Member | 18-01-2023 | - |
Loopbaan van Anne Borgman
Eerdere bekende functies van Anne Borgman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01-01-2019 | 01-03-2022 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01-11-2012 | 01-07-2019 |
| The University of Chicago | Corporate Officer/Principal | 01-01-2001 | 01-01-2010 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01-11-2007 | 01-11-2007 |
| Kalobios Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van Anne Borgman
| University of Illinois | Undergraduate Degree |
| Stritch School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 13 |
| Ierland | 2 |
Operationeel
| Corporate Officer/Principal | 7 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoraal
| Health Technology | 10 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 7 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| EXELIXIS, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| SUTRO BIOPHARMA, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| NEXTCURE, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Health Technology |
| Kalobios Pharmaceuticals, Inc. |
- Beurs
- Insiders
- Anne Borgman
- Ervaring
